Continuos Body Temperature Monitoring

Last updated: March 24, 2025
Sponsor: Baby FM Doo
Overall Status: Active - Recruiting

Phase

N/A

Condition

Fever

Treatment

Continous body temperature monitoring

Clinical Study ID

NCT06447337
BABYFM-010
  • Ages > 18
  • All Genders

Study Summary

This is a nonrandomized, diagnostic, single-center, pilot study, with one group of participants. The aim is to examine the effectiveness and safety of telemedicine system for continuous measurement of body temperature in adults. Up to 40 subjects will participate in this phase of the clinical trial. No stratification, nor randomization of subjects will be performed. Respondents who meet the inclusion criteria will be monitored for up to 72 hours plus 72 hours after removing the device. Namely, the device will be placed on their body and will be there until upt to 72 hours, and then it will be removed. The respondent will be monitored by the team for an additional 72 hours by the person in charge of the examination, for possible side effects.

Sensor will be placed in the axilar joint or a little below on the side. The device will be connected to a mobile phone. Member of the research team (principal researcher/co-researcher/ nurse in charge of examination) measures the temperature of the skin in the opposite armpit manually, ie with a gallium thermometer and records every 30-60 minutes. When body temperature starts to rise, a member of the research team measures the body temperature every 15-30 minutes. After reaching a stable temperature, the temperature is measured every 30-60 minutes. If the subject is given drugs to lower body temperature, the temperature is measured again every 15-30 minutes until the temperature stabilizes to a normal subfebrile state.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • A person of male or female sex

  • Age 18 and over

  • Ability to measure the patient's body temperature frequently

  • People who are hospitalized due to any type of infection or any other diseases thatresult in variations in body temperature (rise, fall)

  • Completed all potential diagnostics of the hospitalized patient (no interrupting themeasurement of the telemedicine device)

Exclusion

Exclusion Criteria:

  • Allergic to contact with plastic or silver

  • Anatomical anomalies that prevent the placement of the system

  • High-risk health conditions, intensive care and the like

  • A pacemaker or other device on the skin or implanted in the body that emits lightelectromagnetic radiation

Study Design

Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Continous body temperature monitoring
Phase:
Study Start date:
December 16, 2024
Estimated Completion Date:
August 30, 2025

Connect with a study center

  • University Clinical Center of Serbia, Clinic for Infectious and Tropical Diseases

    Belgrade, Other/Not Applicable 11000
    Serbia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.